Veizaga Marvin 4

What Happened

• Marvin Veizaga, Chief Accounting Officer of Cross Country Healthcare, had company shares converted into cash in connection with the company’s merger. Two dispositions to the issuer show 31,480 shares and 16,797 shares canceled at $13.25 per share for proceeds of $417,110 and $222,560, respectively (total proceeds $639,670). The filing also shows a corresponding award/acquisition of 16,797 restricted shares at $0.00, reflecting vesting/cancellation treatment prior to cash conversion.

Key Details

• Transaction date: 2026-07-21. Price (Merger Consideration): $13.25 per share.
• Dispositions: 31,480 shares → $417,110; 16,797 shares → $222,560. Total cash received: $639,670 for 48,277 shares.
• Acquisition entry: 16,797 restricted shares shown as granted/converted at $0.00 (reflects vesting/cancellation under merger terms).
• Footnotes: Transactions occurred under the May 6, 2026 Merger Agreement—each outstanding common share was converted into the right to receive $13.25 in cash; restricted and performance-based awards vested (at target) and were cancelled for cash equal to shares × $13.25.
• Shares owned after the transactions: not specified in the filing. Filing date equals transaction date (timely).

Context

• These are merger-related conversions rather than open-market sales. Disposition code "D" (to issuer) indicates shares were surrendered/cancelled in the merger for cash consideration. The award entry (code "A") shows restricted/performance awards vested and were converted to cash per the merger terms. Such filings reflect deal payouts rather than a trading decision by the insider.